121 related articles for article (PubMed ID: 2049319)
21. Detection of bone marrow infiltration by non-Hodgkin's lymphoma--comparison of histological findings, analysis of gene rearrangements, and examination by magnetic resonance imaging.
Knauf WU; Gückel F; Döhner H; Semmler W; Trümper L; Ho AD
Klin Wochenschr; 1991 May; 69(8):345-50. PubMed ID: 1653380
[TBL] [Abstract][Full Text] [Related]
22. 18-F-fluorodeoxyglucose-positron emission tomography as a new approach to detect lymphomatous bone marrow.
Moog F; Bangerter M; Kotzerke J; Guhlmann A; Frickhofen N; Reske SN
J Clin Oncol; 1998 Feb; 16(2):603-9. PubMed ID: 9469348
[TBL] [Abstract][Full Text] [Related]
23. Cost analysis and quality of life assessment comparing patients undergoing autologous peripheral blood stem cell transplantation or autologous bone marrow transplantation for refractory or relapsed non-Hodgkin's lymphoma or Hodgkin's disease. a prospective randomised trial.
van Agthoven M; Vellenga E; Fibbe WE; Kingma T; Uyl-de Groot CA
Eur J Cancer; 2001 Sep; 37(14):1781-9. PubMed ID: 11549432
[TBL] [Abstract][Full Text] [Related]
24. Allogeneic bone marrow transplantation for relapsed and refractory Hodgkin's disease and non-Hodgkin's lymphoma.
Dann EJ; Daugherty CK; Larson RA
Bone Marrow Transplant; 1997 Sep; 20(5):369-74. PubMed ID: 9339751
[TBL] [Abstract][Full Text] [Related]
25. High-dose therapy and autologous bone marrow transplantation for relapsed/refractory Hodgkin's disease: the impact of involved field radiotherapy on patterns of failure and survival.
Poen JC; Hoppe RT; Horning SJ
Int J Radiat Oncol Biol Phys; 1996 Aug; 36(1):3-12. PubMed ID: 8823253
[TBL] [Abstract][Full Text] [Related]
26.
Hassan A; Siddique M; Bashir H; Riaz S; Wali R; Mahreen A; Nawaz MK
Eur J Nucl Med Mol Imaging; 2017 Jul; 44(7):1198-1206. PubMed ID: 28229191
[TBL] [Abstract][Full Text] [Related]
27. Economic analysis of a randomized clinical trial to compare filgrastim-mobilized peripheral-blood progenitor-cell transplantation and autologous bone marrow transplantation in patients with Hodgkin's and non-Hodgkin's lymphoma.
Smith TJ; Hillner BE; Schmitz N; Linch DC; Dreger P; Goldstone AH; Boogaerts MA; Ferrant A; Link H; Zander A; Yanovich S; Kitchin R; Erder MH
J Clin Oncol; 1997 Jan; 15(1):5-10. PubMed ID: 8996118
[TBL] [Abstract][Full Text] [Related]
28. Thoracic radiation therapy before autologous bone marrow transplantation in relapsed or refractory Hodgkin's disease. PMH Lymphoma Group, and the Toronto Autologous BMT Group.
Tsang RW; Gospodarowicz MK; Sutcliffe SB; Crump M; Keating A
Eur J Cancer; 1999 Jan; 35(1):73-8. PubMed ID: 10211091
[TBL] [Abstract][Full Text] [Related]
29. [Results of a series of 104 consecutive bilateral bone marrow biopsy specimens in lymphoproliferative disorders].
Almeida J; García-Marcos MA; Vallejo C; Flores MT; Caballero MD; San Miguel JF; Ríos A
Sangre (Barc); 1995 Oct; 40(5):365-8. PubMed ID: 8553169
[TBL] [Abstract][Full Text] [Related]
30. Treatment of refractory and relapsed Hodgkin's disease: intensive chemotherapy and autologous bone marrow or peripheral blood stem cell support.
Hurd DD; Haake RJ; Lasky LC; Christiansen NP; McGlave PB; Bostrom B; Levine EG; Weisdorf DJ; Kim TH; Peterson BA
Med Pediatr Oncol; 1990; 18(6):447-53. PubMed ID: 1978232
[TBL] [Abstract][Full Text] [Related]
31. Can [18F]fluorodeoxyglucose positron emission tomography imaging complement biopsy results from the iliac crest for the detection of bone marrow involvement in patients with malignant lymphoma?
Fuster D; Chiang S; Andreadis C; Guan L; Zhuang H; Schuster S; Alavi A
Nucl Med Commun; 2006 Jan; 27(1):11-5. PubMed ID: 16340718
[TBL] [Abstract][Full Text] [Related]
32. Single high-dose etoposide and melphalan with non-cryopreserved autologous marrow rescue as primary therapy for relapsed, refractory and poor-prognosis Hodgkin's disease.
Seymour LK; Dansey RD; Bezwoda WR
Br J Cancer; 1994 Sep; 70(3):526-30. PubMed ID: 8080741
[TBL] [Abstract][Full Text] [Related]
33. Repopulation of marrow after transplantation: MR imaging with pathologic correlation.
Stevens SK; Moore SG; Amylon MD
Radiology; 1990 Apr; 175(1):213-8. PubMed ID: 2315483
[TBL] [Abstract][Full Text] [Related]
34. Bilateral trephine bone marrow biopsy for staging non-Hodgkin's lymphoma--a second look.
Ebie N; Loew JM; Gregory SA
Hematol Pathol; 1989; 3(1):29-33. PubMed ID: 2745358
[TBL] [Abstract][Full Text] [Related]
35. Allogeneic bone marrow transplant is not better than autologous transplant for patients with relapsed Hodgkin's disease. European Group for Blood and Bone Marrow Transplantation.
Milpied N; Fielding AK; Pearce RM; Ernst P; Goldstone AH
J Clin Oncol; 1996 Apr; 14(4):1291-6. PubMed ID: 8648386
[TBL] [Abstract][Full Text] [Related]
36. Patterns of failure following high-dose chemotherapy and autologous bone marrow transplantation with involved field radiotherapy for relapsed/refractory Hodgkin's disease.
Mundt AJ; Sibley G; Williams S; Hallahan D; Nautiyal J; Weichselbaum RR
Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):261-70. PubMed ID: 7673013
[TBL] [Abstract][Full Text] [Related]
37. Bone morphology after bone marrow transplantation for Hodgkin's and non-Hodgkin's lymphoma.
Michelson JD; Gornet M; Codd T; Torres J; Lanighan K; Jones R
Exp Hematol; 1993 Mar; 21(3):475-82. PubMed ID: 8440346
[TBL] [Abstract][Full Text] [Related]
38. Magnetic resonance imaging of the bone marrow in patients with acute leukemia during and after chemotherapy. Changes in T1 relaxation.
Jensen KE; Grundtvig Sørensen P; Thomsen C; Christoffersen P; Henriksen O; Karle H
Acta Radiol; 1990 Jul; 31(4):361-9. PubMed ID: 2206692
[TBL] [Abstract][Full Text] [Related]
39. The treatment of relapsed or refractory intermediate grade non-Hodgkin's lymphoma with autologous bone marrow transplantation followed by cyclosporine and interferon.
Gryn J; Johnson E; Goldman N; Devereux L; Grana G; Hageboutros A; Fernandez E; Constantinou C; Harrer W; Viner E; Goldberg J
Bone Marrow Transplant; 1997 Feb; 19(3):221-6. PubMed ID: 9028549
[TBL] [Abstract][Full Text] [Related]
40. Autologous bone marrow transplantation for Hodgkin's and non-Hodgkin's lymphoma.
Kessinger A; Nademanee A; Forman SJ; Armitage JO
Hematol Oncol Clin North Am; 1990 Jun; 4(3):577-87. PubMed ID: 1972701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
